variant of unknown significance in the head domain of K3, which also represents the first potential mutation in either KRT3 or KRT12 associated with MECD that is not located within a helix-initiation or helix-termination motif.
METHODS
Two individuals referred to one of the authors (AJA) were recruited for this study. Proband 1 is a 60-year-old man, and proband 2 is an 8-year-old boy, both otherwise healthy at the time of enrollment. The mother and father of proband 2 were also recruited. Informed consent was obtained from all subjects according to the tenets of the Declaration of Helsinki, and the study adhered to the ARVO statement on human subjects. The Institutional Review Board at the University of California, Los Angeles approved the study described herein (UCLA IRB #11-000020).
Slit-lamp imaging, DNA collection, and preparation: Saliva samples were collected from both probands and the parents of proband 2 using the Oragene Saliva Collection Kit (DNA Genotek, Inc., Ottawa, Canada). Genomic DNA was extracted from buccal epithelial cells using the Oragene prepIT•L2P protocol for genomic DNA purification (DNA Genotek, Inc.). Slit-lamp biomicroscopic imaging was performed for all individuals from whom DNA was collected.
PCR and gel extraction:
The exonic regions of KRT3 and KRT12 were amplified using custom designed primers (Appendix 1). Reactions were prepared as 25 μl mixtures containing 1X KAPA GC/A buffer (Kapa Biosystems, In silico protein analysis: A web tool (DNAtoprotein) was used to generate an in silico translation of the mutant KRT3 and KRT12 sequences. PolyPhen-2, SIFT, and PANTHER were used to predict the functional impact of the identified variants. ConSurf was used to predict the evolutionary conservation of the amino acids affected by each identified variant.
RESULTS

Clinical findings:
Case 1-A 60-year-old Caucasian man (proband 1) with a history of corneal epitheliopathy since age 2 was examined by two of the authors (S.X.D. and A.J.A.). He reported experiencing episodes of foreign body sensation, tearing, stinging, photophobia, and decreased visual acuity approximately every 6 months. Corneal epithelial debridement had been performed previously, with relief of symptoms for up to 1 year. Corrected distance visual acuity (CDVA) measured 20/20 OU, and slit-lamp biomicroscopic examination revealed bilateral, diffusely distributed, fine, clear epithelial microcysts ( Figure 1A ). Given the confluent nature of the fine epithelial microcysts, the cornea demonstrated a stippled appearance following the instillation of fluorescein dye ( Figure 1B ). The proband's parents were deceased, he had no siblings, and his only offspring, a daughter, was not available for examination or genetic testing. Genetic screening: Screening of KRT3 in proband 1 revealed three heterozygous missense variants and one synonymous substitution, but screening of KRT12 demonstrated one heterozygous missense variant (Appendix 2). Each identified variant has been reported to be present in more than 5% of the population, except c.250C>T (p.(Arg84Trp)) in KRT3 exon 1, which corresponds to the head domain of the K3 protein ( Figure 2A ). The presence of the variant was confirmed with forward and reverse sequencing, and by sequencing with a second primer pair. Although the variant was not identified in 200 control chromosomes, it has been reported to be present in 80/66,638 Europeans (0.1%) and 186/10,380 Africans (1.8%) according to the Exome Aggregation Consortium browser database, with an overall minor allele frequency (MAF) of 0.0076 per the dbSNP and 1000 Genomes databases.
Screening of KRT3 in proband 2 demonstrated two of the three missense variants and the synonymous substitution identified in proband 1, each homozygous (Appendix 2). Screening of KRT12 demonstrated a novel heterozygous insertion/deletion variant (indel), c.1288_1293delCGCCGCinsAGCCCT (p.(Arg430_Arg431delinsSerPro)), in the helix-termination motif. The presence of this variant in exon 6 was confirmed with forward and reverse sequencing, and by sequencing with a second primer pair. The variant was not identified in the unaffected mother or father of the proband, or in 200 control chromosomes. Genotyping of the proband and his parents confirmed (with greater than 99.999% certainty) that the proband's mother and father were his biological parents (Table 2) .
Protein in silico analysis:
In silico analysis with PolyPhen-2 and PANTHER predicted p.(Arg84Trp) in K3 to be likely damaging to protein function; however, SIFT analysis predicted that the missense change would be tolerated (Table  3 ). In addition, ConSurf assigned amino acid 84 of K3 a score of 4 (scale: 1-9), indicative of slightly variable conservation across species.
Both missense mutations identified in KRT12 in proband 2, p.(Arg430Ser) and p.(Arg431Pro), were predicted to be damaging to the function of the encoded protein by all three protein prediction tools. ConSurf calculations assigned amino acid 430 a score of 9, which indicates the highest level of conservation across species, and amino acid 431 a score of 5, which indicates average conservation across species.
DISCUSSION
Keratins are a group of structural proteins in the epithelia of the skin, hair, nails, and cornea. These proteins occur as obligate heteropolymers, assembled from dimers composed of type I and type II intermediate filaments. In the cornea, the type I intermediate filament is K12, but the type II intermediate filament is K3 [11] . Structurally, intermediate filaments consist of an N-terminal head domain, a central α-helical rod domain that begins with a helix-initiation motif and ends with a helix-termination motif, and a C-terminal tail domain ( Figure 3 ) [12, 13] . The rod domain, and in particular the helix boundary motifs, is highly conserved across species. Thus, mutations in this region often substantially alter the structure of the encoded keratin protein and negatively impact keratin function [14, 15] . Specifically, mutations in the helix boundary motifs have been observed to compromise intermediate filament assembly during the early stages of filament elongation, resulting in cytoplasmic filament clumping and more severe disease phenotypes than those associated with mutations of other keratin protein domains [11, 14, 16] . Keratin gene mutations have consequently been linked to several tissuespecific fragility syndromes, with certain features commonly observed, such as cytolysis, hyperkeratosis, and filament aggregation [16] . The head domain, while fairly conserved, varies the most between tissue-specific keratins, and therefore accounts for the diversity of keratins among epithelia [16] . In contrast to the helical rod domains, which form the backbone of the keratin filaments and are responsible for maintaining the structural integrity of the heterodimer unit, the head domain plays a more significant role in higher-order intermediate filament assembly [12, 16] . These assembly functions include intermediate filament organization, dimer binding to form heterotetramers, and end-to-end linkage of the polymers to form keratin filaments [12, 17] .
Though not yet well understood, the ability of the head domain to confer tissue-specific properties to keratins is attributed to post-translational modification of this region, which possesses numerous sites that serve as substrates for phosphorylation [11, 17] .
Before this report, no keratin mutations in the head domain of either K3 or K12 had been identified that are presumed to cause MECD, although head domain mutations in other keratin proteins have been implicated in various dermatologic disorders, including epidermolysis bullosa simplex [11] . Nielsen et al. previously reported two single Arg19Trp) ), in the head domain of K12 in a family with ocular findings of MECD [18] . However, neither of the SNVs is likely pathogenic, as the MAF for each of these variants is 0.3095 and 0.0537, respectively, and the affected family members harbored a presumed pathogenic novel heterozygous mutation in the helix-initiation motif of K12. The K3 mutation we report in proband 1 is the sole coding region variant identified in KRT3 and KRT12 with an MAF of less than 0.05, although the associated MAF of 0.0076 is likely greater than the population prevalence of MECD. Additionally, although PolyPhen-2 and PANTHER predicted the variant to be damaging to protein function, SIFT analysis predicted tolerance of the variant. Despite the questions regarding the variant's pathogenicity, it remains possible that the variant is associated with MECD, given the well-established association between keratin mutations and MECD. Unfortunately, as the parents of the proband were unavailable for examination, we were unable to establish an association between p.(Arg84Trp) in KRT3 and MECD in other members of this family, and thus present it as a variant of uncertain significance.
Previous studies by Liao et al. and Allen et al. provided a proposed mechanism for how identified KRT3 and KRT12 mutations lead to the development of the corneal epithelial abnormalities that characterize Meesmann corneal dystrophy [19, 20] . These investigators demonstrated a disruption of the normal intracellular keratin filament formation in cultured corneal epithelial cells transfected with mutant cDNA constructs, as well as rescue of normal keratin filament Note: There is a greater than 99.999% percent probability that both parents are the biologic parents. formation with allele-specific siRNA inhibition of the mutant allele [19, 20] . Although it is likely that each of the identified mutations in KRT3 and KRT12, including those that we report, also causes a disruption of the intracellular keratin filament network, similar functional studies must be performed to provide additional evidence for, or alternatively, to provide evidence against, the pathogenicity of each variant.
To date, all 25 mutations in KRT3 and KRT12 identified in individuals with MECD have been located in the helix boundary motifs of the respective keratin proteins (Figure 3 ). The majority (15/25) of the mutations are in the helix-initiation motif of K12; the remainder are in the helix-termination motifs of K3 and K12. We present a novel mutation, and the first reported indel, in KRT12 associated with a previously unreported phenotype of MECD, which we demonstrate to have arisen spontaneously. De novo mutations have been identified in three other genes associated with corneal dystrophies: TGFBI (gene ID #21810; OMIM #601692); ZEB1 (gene ID #21417; OMIM #189909), associated with posterior polymorphous corneal dystrophy 3; and UBIAD1 (gene ID #29914; OMIM #611632; associated with Schnyder corneal dystrophy) [21] [22] [23] [24] [25] . Such cases of de novo dominantly inherited corneal dystrophies highlight the utility of molecular genetic analysis to confirm the diagnosis of a suspected corneal dystrophy that is questioned given the absence of a family history. We also report a missense mutation of unknown significance in KRT3, only the fourth to be associated with MECD and the first in the head domain of K3. Although this variant has not been demonstrated to be pathogenic, the possibility that disease-causing variants associated with MECD may not be restricted to primary sequence alterations of either the helixinitiation or helix-termination motifs of K3 and K12 should be considered.
APPENDIX 1. PRIMER SEQUENCES AND CONDITIONS USED FOR PCR.
Note: letters indicate primer pairs amplifying different regions of an exon, whereas numbers indicate alternative primer pairs used to sequence the entirety of an exon. To access the data, click or select the words "Appendix 1." 
